HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.

by Jorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, Jesús Troya, Guillermo Cuevas, Jorge Gutiérrez, Santiago Moreno
Published 2018-01-01

Improvisation in times of pandemic, a reason for reflection

by Jesús Troya, MD PHD, Luis Miguel Seijo, MD PHD, Mario Pérez, MD, Lucia Sentchordi-Montane, MD, Álvaro Martínez-Alcalá, MD
Published 2020-07-01

Gender-based vulnerability in women who inject drugs in a harm reduction setting.

by Jorge Valencia, Alejandro Alvaro-Meca, Jesús Troya, Jorge Gutiérrez, Cristina Ramón, Antonio Rodríguez, Sonia Vázquez-Morón, Salvador Resino, Santiago Moreno, Pablo Ryan
Published 2020-01-01

HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study

by Pablo Ryan, Jorge Valencia, Guillermo Cuevas, Jesús Troya, Juan Torres-Macho, María José Muñoz-Gómez, Nuria Muñoz-Rivas, Isabel Canorea, Sonia Vázquez-Morón, Salvador Resino
Published 2021-08-01

Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.

by Jesús Troya, Rocio Montejano, Pablo Ryan, Cristina Gómez, Mariano Matarranz, Alfonso Cabello, Francisco Vera, María Antonia Sepúlveda, Ignacio Santos, Gloria Samperiz, Pablo Bachiller, Vicente Boix, Pilar Barrufet, Miguel Cervero, José Sanz, Javier Solís, María Yllescas, Eulalia Valencia, GESIDA-8715 Study Group
Published 2018-01-01

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

by Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group
Published 2017-01-01

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

by Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group
Published 2016-01-01

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection

by Óscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, Javier Crespo García, Pablo Ryan Murúa, Juan Macías, Joaquín Cabezas González, Jesús Troya, Juan Antonio Pineda, María Teresa Arias Loste, Victorino Díez Viñas, María Ángeles Jiménez-Sousa, Luz María Medrano de Dios, Isabel Cuesta De la Plaza, Sara Monzón Fernández, Salvador Resino García, Amanda Fernández-Rodríguez
Published 2019-06-01

Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study.

by Helen Dolengevich-Segal, Alicia Gonzalez-Baeza, Jorge Valencia, Eulalia Valencia-Ortega, Alfonso Cabello, Maria Jesus Tellez-Molina, Maria Jesus Perez-Elias, Regino Serrano, Leire Perez-Latorre, Luz Martin-Carbonero, Sari Arponen, Jose Sanz-Moreno, Sara De la Fuente, Otilia Bisbal, Ignacio Santos, Jose Luis Casado, Jesus Troya, Miguel Cervero-Jimenez, Sara Nistal, Guillermo Cuevas, Javier Correas-Lauffer, Marta Torrens, Pablo Ryan, U-SEX GESIDA 9416 Study
Published 2019-01-01

Epigenome-wide association study of COVID-19 severity with respiratory failure

by Manuel Castro de Moura, Veronica Davalos, Laura Planas-Serra, Damiana Alvarez-Errico, Carles Arribas, Montserrat Ruiz, Sergio Aguilera-Albesa, Jesús Troya, Juan Valencia-Ramos, Valentina Vélez-Santamaria, Agustí Rodríguez-Palmero, Judit Villar-Garcia, Juan P. Horcajada, Sergiu Albu, Carlos Casasnovas, Anna Rull, Laia Reverte, Beatriz Dietl, David Dalmau, Maria J. Arranz, Laia Llucià-Carol, Anna M. Planas, Jordi Pérez-Tur, Israel Fernandez-Cadenas, Paula Villares, Jair Tenorio, Roger Colobran, Andrea Martin-Nalda, Pere Soler-Palacin, Francesc Vidal, Aurora Pujol, Manel Esteller
Published 2021-04-01

Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study

by Ane Abad-motos, Jesús Troya, Eva Jiménez, Mario Fontán-Vela, Jorge Valencia, Ines Fernandez-Jimenez, Elena Alba Álvaro-Alonso, Elsa Izquierdo-García, Andrea Lazaro Cebas, Elisa Gallego Ruiz-Elvira, Ana Josefa Tebar-Martinez, Belén Garcia-Marina, Gabriela Peña-Lillo, Laura Macaya, Mario Pérez-Butragueño, Blanca Herrero Mendoza, Natividad Plazas Andreu, Liliana Vázquez Bol, Sandra María Gadin López, Álvaro Martínez Alcalá, Sonia Pérez Gonzalez, Amalia Martínez de la Gándara, Alejandro Zuazua Gonzalez, Javier Montoya Adarraga, Miguel Ángel Lara Álvarez, Enrique Calvo Aranda, Rosa M Lorente Ramos, María Alcantud, Roberto Alcázar Arroyo, Verónica Suberviola Sánchez-Caballero, Ariela Candelario Cáceres, Juan Churruca Sarasqueta, Juan Torres Macho, Ismael Escobar Rodríguez, Raquel Ruíz Páez, Alberto Esquivel López, Pablo de la Cueva Dobao, Natalia Blanca López, José García Hinojosa, Cristina Sevillano Collantes, Alfonso Camacho Aroca, Tamar Talaván Zañón, María Ángeles Sánchez Úriz, Carlos Bibiano Guillén, Miguel Ángel López Arenas, Margarita Gimeno Arández, Francisco Javier Quintero Gutiérrez del Álamo
Published 2020-11-01